/Companies

cTRL Therapeutics

1 known investors

Find your way into cTRL Therapeutics

Sign up to see every warm intro you have to cTRL Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the cTRL Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

cTRL is a biotech company developing cell-based immunotherapies for cancer, drawing on expertise in the adaptive immune system, immuno-oncology, biomedical engineering, and cell therapy research and development.

Investors · 1

Frequently asked questions

What does cTRL Therapeutics do?
cTRL is a biotech company developing cell-based immunotherapies for cancer, drawing on expertise in the adaptive immune system, immuno-oncology, biomedical engineering, and cell therapy research and development.
Who are cTRL Therapeutics's investors?
cTRL Therapeutics's investors include Portal Innovations.